Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10666699 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature